文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

神经重症患者的拔管:ENIO国际前瞻性研究

Extubation in neurocritical care patients: the ENIO international prospective study.
PubMed 文献 · Intensive Care Med · 2022-08-29
一句话结论神经重症患者拔管失败率19.4%,失败者机械通气时间更长、ICU死亡率更高;新预测评分训练队列AUC 0.79、验证队列0.71。

ENIO(NCT03400904)为2018至2020年在18个国家73个ICU开展的国际前瞻性观察研究,纳入GCS≤12、机械通气≥24小时的神经重症患者。1193例(78.9%)尝试拔管者中231例(19.4%)拔管失败。成功拔管预测评分保留20个独立预测变量,训练队列AUC 0.79(95%CI 0.71-0.87),验证队列AUC 0.71(95%CI 0.61-0.81)。拔管失败者机械通气时间更长(14[7-21]天 vs 6[3-11]天)、ICU死亡率更高(8.7% vs 2.4%)。

要点

  • 神经重症患者(GCS≤12、机械通气≥24小时)拔管失败率为19.4%(1193例尝试拔管者中231例失败)。
  • 拔管失败者机械通气时间14[7-21]天 vs 6[3-11]天,ICU死亡率8.7% vs 2.4%,均高于拔管成功者。
  • 成功拔管预测评分含20个独立预测变量,训练队列AUC 0.79(95%CI 0.71-0.87),验证队列AUC 0.71(95%CI 0.61-0.81)。
  • 319例(21.1%)未尝试拔管直接行气管切开,其机械通气时间更长、ICU死亡率高于尝试拔管者(无论成功或失败)。
  • 作者认为该评分可在多种场景预测拔管成功,但必须在另一独立前瞻性队列中验证。

适用人群与场景

  • 神经重症患者,GCS≤12,接受有创机械通气≥24小时,并进行拔管尝试或气管切开;研究在18个国家73个ICU开展。

诊断标准与关键阈值

  • 纳入标准:GCS≤12,有创机械通气≥24小时,进行拔管尝试或气管切开。
  • 主要终点:第5天拔管失败。

研究设计与关键结果

  • ENIO为国际前瞻性观察研究,2018至2020年18个国家73个ICU,纳入1512例患者。
  • 1193例(78.9%)尝试拔管,其中231例(19.4%)拔管失败。
  • 成功拔管预测评分保留20个独立预测变量;训练队列AUC 0.79(95%CI 0.71-0.87),验证队列AUC 0.71(95%CI 0.61-0.81)。
  • 拔管失败者机械通气时间14[7-21]天 vs 6[3-11]天,ICU死亡率8.7% vs 2.4%,均高于拔管成功者。
  • 319例(21.1%)未尝试拔管直接行气管切开;直接气管切开者机械通气时间更长、ICU死亡率高于尝试拔管者(成功和失败)。

证据类型、等级与局限

  • 证据类型:国际前瞻性观察研究(ENIO,NCT03400904)。
  • 局限:作者认为必须在另一独立前瞻性队列中验证该评分。

对床旁实践的改变

  • 在神经重症患者中,拔管失败率较高且与不良结局相关;作者认为新评分可在多种场景预测拔管成功,但需在另一独立前瞻性队列中验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Neurocritical care patients receive prolonged invasive mechanical ventilation (IMV), but there is poor specific information in this high-risk population about the liberation strategies of invasive mechanical ventilation.

METHODS: ENIO (NCT03400904) is an international, prospective observational study, in 73 intensive care units (ICUs) in 18 countries from 2018 to 2020. Neurocritical care patients with a Glasgow Coma Score (GCS) ≤ 12, receiving IMV ≥ 24 h, undergoing extubation attempt or tracheostomy were included. The primary endpoint was extubation failure by day 5. An extubation success prediction score was created, with 2/3 of patients randomly allocated to the training cohort and 1/3 to the validation cohort. Secondary endpoints were the duration of IMV and in-ICU mortality.

RESULTS: 1512 patients were included. Among the 1193 (78.9%) patients who underwent an extubation attempt, 231 (19.4%) failures were recorded. The score for successful extubation prediction retained 20 variables as independent predictors. The area under the curve (AUC) in the training cohort was 0.79 95% confidence interval (CI95) [0.71-0.87] and 0.71 CI95 [0.61-0.81] in the validation cohort. Patients with extubation failure displayed a longer IMV duration (14 [7-21] vs 6 [3-11] days) and a higher in-ICU mortality rate (8.7% vs 2.4%). Three hundred and nineteen (21.1%) patients underwent tracheostomy without extubation attempt. Patients with direct tracheostomy displayed a longer duration of IMV and higher in-ICU mortality than patients with an extubation attempt (success and failure).

CONCLUSIONS: In neurocritical care patients, extubation failure is high and is associated with unfavourable outcomes. A score could predict extubation success in multiple settings. However, it will be mandatory to validate our findings in another prospective independent cohort.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Cinotti R, Mijangos JC, Pelosi P, et al. Extubation in neurocritical care patients: the ENIO international prospective study. Intensive Care Med. 2022. PMID: 36038713. doi:10.1007/s00134-022-06825-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。